Condition
Mitral Annulus Calcification
Total Trials
6
Recruiting
2
Active
2
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Recruiting2
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07069673Recruiting
Abbott Cephea Mitral Valve Disease Registry
NCT06952374Not ApplicableRecruitingPrimary
Treating Severe Mitral Valve Annular or Valvular Calcification Using Shockwave Balloon SMARTWAVE
NCT03539458Not ApplicableCompleted
Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification
NCT04286009CompletedPrimary
Pathogenesis and Mechanisms of Mitral Annular Calcification
NCT04093973CompletedPrimary
Bicycle Exercise Echocardiography to Assess Physiological Significance of Mitral Annular Calcification
NCT01442467TerminatedPrimary
Study of Echocardiogram Accuracy in Patients With Mitral Valve Calcification
Showing all 6 trials